-
THE KIDS' PROS MAY NOT BE ALRIGHT: NOVEL METHODS FOR ASSESSING THE SUITABILITY OF EXISTING PEDIATRIC PROS FOR USE WITH CHILDREN, AND DATA TO SUPPORT IMPROVED WORDING AND DESIGN
Aug 11, 2026, 17:16 PM -
PATIENT CONTRIBUTIONS AND CHANGES IN COVERAGE RECOMMENDATIONS (2021-2025): EVIDENCE FROM PUBLIC CONSULTATIONS IN BRAZIL'S SUPPLEMENTARY HEALTH SYSTEM
Aug 11, 2026, 17:16 PM -
REGULATORY REALITY VERSUS MEASUREMENT AMBITION: CLINICAL OUTCOME ASSESSMENTS (COA) AND CONCEPT COVERAGE IN OBESITY LABELS AND GUIDELINES ACROSS FDA AND EMA
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF GLOFITAMAB PLUS GEMCITABINE AND OXALIPLATIN FOR THE SECOND-LINE TREATMENT OF AUTOLOGOUS STEM CELL TRANSPLANT INELIGIBLE RELAPSED/REFRACTORY DLBCL FROM A UK HEALTHCARE SYSTEM PERSPECTIVETRANSPLANT INELIGIBLE...
Aug 11, 2026, 17:16 PM -
MEASURING ACTIVITY, NOT DELIVERY: RE-EXAMINING THE EU HTA REGULATION'S FOUNDING IMPACT ASSESSMENT
Aug 11, 2026, 17:16 PM -
LONG-TERM HEALTH OUTCOMES SIMULATION OF SERPLULIMAB FOR PD-L1-POSITIVE, LOCALLY ADVANCED, RESECTABLE GASTRIC/GASTRO-OESOPHAGEAL JUNCTION ADENOCARCINOMA PATIENTS IN CHINA
Aug 11, 2026, 17:16 PM -
A SIMULATION STUDY OF AREA-UNDER-THE CURVE MATCHING-ADJUSTED INDIRECT COMPARISON FOR ROBUST LONGITUDINAL TREATMENT EVALUATION
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESSOF THE SYMPLICITY SPYRAL™ RENAL DENERVATION SYSTEM IN ADULTS WITH UNCONTROLLED HYPERTENSION IN TURKIYE
Aug 11, 2026, 17:16 PM -
REAL-WORLD DRIVERS OF CLINICAL DECISION-MAKING IN ATRIAL FIBRILLATION: UNDERSTANDING SUBJECTIVE REASONS FOR NON-USE OF ORAL ANTICOAGULANTS
Aug 11, 2026, 17:16 PM -
CRITICAL ASSESSMENT OF PRICING PATHWAYS AND REGULATORY CLASSIFICATION OF ATMPS APPROVED IN BRAZIL
Aug 11, 2026, 17:16 PM -
ALIGNING MANAGED ENTRY AGREEMENTS WITH VALUE-BASED HEALTHCARE: A CONCEPTUAL FRAMEWORK BASED ON THE EUROPEAN UNION VALUE-BASED HEALTHCARE PILLARS
Aug 11, 2026, 17:16 PM -
MAINTAINING CONCEPTUAL EQUIVALENCE IN LINGUISTIC VALIDATION FOR LINGUISTICALLY UNDERSERVED LANGUAGES: CHALLENGES AND PRACTICAL SOLUTIONS FROM LAO, KHMER, TIGRINYA, AND KINYARWANDA
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF THE BIVALENT RESPIRATORY SYNCYTIAL VIRUS PREFUSION F (RSVPREF) VACCINE IN AT-RISK ADULTS AGED =60 YEARS IN PERU
Aug 11, 2026, 17:16 PM -
COMPARATIVE ANALYSIS OF REGULATORY APPROVAL AND HTA EVALUATION FOR FDA-APPROVED ONCOLOGY THERAPIES ACROSS MFN-BASKET COUNTRIES
Aug 11, 2026, 17:16 PM -
DERIVING A LOCAL COST-EFFECTIVENESS THRESHOLD FROM DIALYSIS EXPENDITURE: IMPLICATIONS FOR RARE KIDNEY DISEASE REIMBURSEMENT
Aug 11, 2026, 17:16 PM -
THE USE AND REPORTING OF CONCEPTUAL MODELS FOR ATTRIBUTE DEVELOPMENT IN PREFERENCE RESEARCH - INSIGHTS FROM A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
SUB-OPTIMAL BIOCHEMICAL AND HEALTH RELATED QUALITY OF LIFE OUTCOMES WITH OFF-LABEL BEZAFIBRATE USE IN PATIENTS WITH PBC: ANALYSIS OF A REAL-WORLD DATASET
Aug 11, 2026, 17:16 PM -
DELIVERING SUSTAINABLE NHS VALUE: OPTIMISING SPEND, CAPACITY, AND CARE PATHWAY PRODUCTIVITY VIA INTERVENTIONAL RADIOLOGY
Aug 11, 2026, 17:16 PM -
THE IMPACT OF INCORPORATING WIDER SOCIETAL COSTS ON THE COST-EFFECTIVENESS OF DISEASE-MODIFYING THERAPIES (DMTS) FOR ALZHEIMER'S DISEASE (AD) AND WHY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) IS YET TO DEMONSTRATE FLEXIBILITY...
Aug 11, 2026, 17:16 PM -
WHY IDENTICAL CARE FEELS LESS TRUSTWORTHY ON A SCREEN: PERCEIVED SOCIAL PRESENCE AND TRUST AS THE MECHANISM BEHIND THE TELEMEDICINE ADOPTION DEFICIT
Aug 11, 2026, 17:16 PM
